null - FindTrial

N/A - TIDOA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-003484-38-FR

Enrollment

Registered

2015-06-19

Start date

2015-01-22

Completion date

Unknown

Last updated

2020-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: LLT Classification code 10016686 Term: Finger osteoarthritis System Organ Class: 100000004859

Interventions

Trade Name: Roche Registration Limited Product Name: RoActemra Product Code: EMEA/H/C/000955 Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: tocilizumab CAS Number: 37

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026